Novorapid Penfill (Insulin Aspart)

Insulin aspart, the active ingredient in Novorapid Penfill, is a rapid-acting insulin analog presented as a solution for subcutaneous injection use. It lowers blood glucose in people with diabetes mellitus. GNH USA supplies Novorapid Penfill as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novorapid Penfill as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novorapid Penfill is a rapid-acting insulin analog that works ​​    ​  ​  ​   ​   ​  ​   ​            ​  ​           ​

- Diabetes mellitus type  
   "); -  ");  \